Skip to main content
OpenTrials

Clinical trial condition

ER Positive Breast Cancer

Explore clinical trials studying ER Positive Breast Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

ER Positive Breast Cancer trial results

Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

NCT07085767

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Clinical Trial Site Hot Springs, Arkansas, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Alamitos, California, United States
View all 167 locations
View Trial Details
Recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

NCT04886531

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Penn State Cancer Institute Hershey, Pennsylvania, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Recruiting

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

NCT06016738

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +8 more
Locations
  • Clinical Trial Site Tucson, Arizona, United States
  • Clinical Trial Site Fountain Valley, California, United States
  • Clinical Trial Site Glendale, California, United States
  • Clinical Trial Site La Jolla, California, United States
View all 233 locations
View Trial Details
Recruiting

PRE-I-SPY Phase I/Ib Oncology Platform Program

NCT05868226

Conditions
Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details

Related conditions